{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:44:21Z","timestamp":1791575061107,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004419","name":"CRDF Global","doi-asserted-by":"publisher","award":["USB1-31149-XX-13"],"award-info":[{"award-number":["USB1-31149-XX-13"]}],"id":[{"id":"10.13039\/100004419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004419","name":"CRDF Global","doi-asserted-by":"publisher","award":["USB1-31149-XX-13"],"award-info":[{"award-number":["USB1-31149-XX-13"]}],"id":[{"id":"10.13039\/100004419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001065"],"award-info":[{"award-number":["AI001065"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasma cytokines are biomarkers of disease extent and mycobacterial burden in pulmonary tuberculosis (PTB). Whether chemokines can perform the same role in PTB is not known. We examined the plasma levels of chemokines in individuals with PTB, latent TB (LTB) or healthy controls (HC) and their association with disease severity and mycobacterial burdens in PTB. We also examined the chemokines in PTB individuals at the end of anti-tuberculous chemotherapy (ATT). PTB individuals exhibited significantly higher levels of CCL1, CCL3, CXCL1, CXCL2, CXCL9 and CXCL10 in comparison to LTB and\/or HC individuals. PTB individuals with bilateral or cavitary disease displayed significantly elevated levels of CCL1, CCL3, CXCL1, CXCL10 and CXCL11 compared to those with unilateral or non-cavitary disease and also exhibited a significant positive relationship with bacterial burdens. In addition, PTB individuals with slower culture conversion displayed significantly elevated levels of CCL1, CCL3, CXCL1 and CXCL9 at the time of PTB diagnosis and prior to ATT. Finally, the chemokines were significantly reduced following successful ATT. Our data demonstrate that PTB is associated with elevated levels of chemokines, which are partially reversed followed chemotherapy. Our data demonstrate that chemokines are markers of disease severity, predicting increased bacterial burden and delayed culture conversion in PTB.<\/jats:p>","DOI":"10.1038\/s41598-019-54803-w","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T11:04:18Z","timestamp":1575371058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Nathella P.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadar","family":"Moideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Nancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaradhya S.","family":"Shruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugam","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-7306","authenticated-orcid":false,"given":"Hardy","family":"Kornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"54803_CR1","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai, M. et al. Tuberculosis. Nat Rev Dis Primers 2, 16076, https:\/\/doi.org\/10.1038\/nrdp.2016.76 (2016).","journal-title":"Nat Rev Dis Primers"},{"key":"54803_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nri.2017.69","volume":"17","author":"AM Cadena","year":"2017","unstructured":"Cadena, A. M., Fortune, S. M. & Flynn, J. L. Heterogeneity in tuberculosis. Nat Rev Immunol 17, 691\u2013702, https:\/\/doi.org\/10.1038\/nri.2017.69 (2017).","journal-title":"Nat Rev Immunol"},{"key":"54803_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra, A. et al. The immune response in tuberculosis. Annu Rev Immunol 31, 475\u2013527, https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095939 (2013).","journal-title":"Annu Rev Immunol"},{"key":"54803_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1440-1711.2000.00933.x","volume":"78","author":"BM Saunders","year":"2000","unstructured":"Saunders, B. M. & Cooper, A. M. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78, 334\u2013341, https:\/\/doi.org\/10.1046\/j.1440-1711.2000.00933.x (2000).","journal-title":"Immunol Cell Biol"},{"key":"54803_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cytogfr.2012.10.002","volume":"24","author":"SR Slight","year":"2013","unstructured":"Slight, S. R. & Khader, S. A. Chemokines shape the immune responses to tuberculosis. Cytokine Growth Factor Rev 24, 105\u2013113, https:\/\/doi.org\/10.1016\/j.cytogfr.2012.10.002 (2013).","journal-title":"Cytokine Growth Factor Rev"},{"key":"54803_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.smim.2014.09.004","volume":"26","author":"L Monin","year":"2014","unstructured":"Monin, L. & Khader, S. A. Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol 26, 552\u2013558, https:\/\/doi.org\/10.1016\/j.smim.2014.09.004 (2014).","journal-title":"Semin Immunol"},{"key":"54803_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00281-015-0531-3","volume":"38","author":"A Dorhoi","year":"2016","unstructured":"Dorhoi, A. & Kaufmann, S. H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin Immunopathol 38, 153\u2013166, https:\/\/doi.org\/10.1007\/s00281-015-0531-3 (2016).","journal-title":"Semin Immunopathol"},{"issue":"6","key":"54803_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.smim.2014.09.011","volume":"26","author":"Marilena Paola Etna","year":"2014","unstructured":"Etna, M. P., Giacomini, E., Severa, M. & Coccia, E. M. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin Immunol 26, 543\u2013551, S1044-5323(14)00095-5 [pii], https:\/\/doi.org\/10.1016\/j.smim.2014.09.011 (2014).","journal-title":"Seminars in Immunology"},{"key":"54803_CR9","first-page":"145","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy, P. M. et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52, 145\u2013176 (2000).","journal-title":"Nomenclature for chemokine receptors. Pharmacol Rev"},{"key":"54803_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/pr.54.2.227","volume":"54","author":"PM Murphy","year":"2002","unstructured":"Murphy, P. M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54, 227\u2013229 (2002).","journal-title":"Pharmacol Rev"},{"key":"54803_CR11","doi-asserted-by":"publisher","first-page":"e16161","DOI":"10.1371\/journal.pone.0016161","volume":"6","author":"DD Kang","year":"2011","unstructured":"Kang, D. D., Lin, Y., Moreno, J. R., Randall, T. D. & Khader, S. A. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS One 6, e16161, https:\/\/doi.org\/10.1371\/journal.pone.0016161 (2011).","journal-title":"PLoS One"},{"key":"54803_CR12","doi-asserted-by":"publisher","first-page":"ofz257","DOI":"10.1093\/ofid\/ofz257","volume":"6","author":"NP Kumar","year":"2019","unstructured":"Kumar, N. P., Moideen, K., Banurekha, V. V., Nair, D. & Babu, S. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. Open Forum Infect Dis 6, ofz257, https:\/\/doi.org\/10.1093\/ofid\/ofz257 (2019).","journal-title":"Open Forum Infect Dis"},{"key":"54803_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mi.2011.13","volume":"4","author":"AM Cooper","year":"2011","unstructured":"Cooper, A. M., Mayer-Barber, K. D. & Sher, A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4, 252\u2013260, https:\/\/doi.org\/10.1038\/mi.2011.13 (2011).","journal-title":"Mucosal Immunol"},{"key":"54803_CR14","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1128\/IAI.01599-13","volume":"82","author":"MT Coleman","year":"2014","unstructured":"Coleman, M. T. et al. Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 82, 2400\u20132404, https:\/\/doi.org\/10.1128\/IAI.01599-13 (2014).","journal-title":"Infect Immun"},{"issue":"5","key":"54803_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri2960","volume":"11","author":"Gerhard Walzl","year":"2011","unstructured":"Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J. & Zumla, A. Immunological biomarkers of tuberculosis. Nat Rev Immunol 11, 343\u2013354, nri2960 [pii], https:\/\/doi.org\/10.1038\/nri2960 (2011).","journal-title":"Nature Reviews Immunology"},{"key":"54803_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tube.2018.05.004","volume":"111","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis (Edinb) 111, 45\u201353, https:\/\/doi.org\/10.1016\/j.tube.2018.05.004 (2018).","journal-title":"Tuberculosis (Edinb)"},{"key":"54803_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","volume":"70","author":"I Wergeland","year":"2015","unstructured":"Wergeland, I. et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect 70, 381\u2013391, https:\/\/doi.org\/10.1016\/j.jinf.2014.12.019 (2015).","journal-title":"J Infect"},{"key":"54803_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cmi.2018.07.017","volume":"25","author":"VS Santos","year":"2019","unstructured":"Santos, V. S. et al. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis. Clin Microbiol Infect 25, 169\u2013177, https:\/\/doi.org\/10.1016\/j.cmi.2018.07.017 (2019).","journal-title":"Clin Microbiol Infect"},{"key":"54803_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/erm.11.97","volume":"12","author":"M Ruhwald","year":"2012","unstructured":"Ruhwald, M., Aabye, M. G. & Ravn, P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 12, 175\u2013187, https:\/\/doi.org\/10.1586\/erm.11.97 (2012).","journal-title":"Expert Rev Mol Diagn"},{"key":"54803_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","volume":"192","author":"M Tebruegge","year":"2015","unstructured":"Tebruegge, M. et al. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. Am J Respir Crit Care Med 192, 485\u2013499, https:\/\/doi.org\/10.1164\/rccm.201501-0059OC (2015).","journal-title":"Am J Respir Crit Care Med"},{"key":"54803_CR21","doi-asserted-by":"publisher","first-page":"e12577","DOI":"10.1371\/journal.pone.0012577","volume":"5","author":"D Goletti","year":"2010","unstructured":"Goletti, D. et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 5, e12577, https:\/\/doi.org\/10.1371\/journal.pone.0012577 (2010).","journal-title":"PLoS One"},{"key":"54803_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jinf.2013.08.005","volume":"68","author":"M Armand","year":"2014","unstructured":"Armand, M. et al. Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study. J Infect 68, 62\u201370, https:\/\/doi.org\/10.1016\/j.jinf.2013.08.005 (2014).","journal-title":"J Infect"},{"issue":"17","key":"54803_CR23","doi-asserted-by":"publisher","first-page":"e3575","DOI":"10.1097\/MD.0000000000003575","volume":"95","author":"Wou Young Chung","year":"2016","unstructured":"Chung, W. Y. et al. The Usefulness of Serum CXCR3 Ligands for Evaluating the Early Treatment Response in Tuberculosis A Longitudinal Cohort Study. Medicine 95, ARTN e3575, https:\/\/doi.org\/10.1097\/MD.0000000000003575 (2016).","journal-title":"Medicine"},{"key":"54803_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.5588\/ijtld.15.0325","volume":"19","author":"W Chung","year":"2015","unstructured":"Chung, W. et al. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. Int J Tuberc Lung D 19, 1476\u20131484, https:\/\/doi.org\/10.5588\/ijtld.15.0325 (2015).","journal-title":"Int J Tuberc Lung D"},{"key":"54803_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.chest.2016.02.675","volume":"149","author":"H Kornfeld","year":"2016","unstructured":"Kornfeld, H. et al. High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Chest 149, 1501\u20131508, https:\/\/doi.org\/10.1016\/j.chest.2016.02.675 (2016).","journal-title":"Chest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54803-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54803-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54803-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:49:09Z","timestamp":1671295749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54803-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54803"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54803-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18217"}}